insights_auto
Why is COR down 2.03%?
Dive Deeperchevron_right
COR:NYSE
Cencora Inc
$341.25
arrow_downward
-2.03%(-7.06) 1D
$341.25
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 19, 4:00:05 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
$345.03
High
$347.73
Low
$337.10
Mkt. cap
15.08B
Avg. vol.
1.34M
Volume
1.41M
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
Open
$345.03
High
$347.73
Low
$337.10
Mkt. cap
15.08B
Avg. vol.
1.34M
Volume
1.41M
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
News stories
From web sources and news partners
ad-hoc-news.de
·
7 hours ago
Cencora stock: Barclays lifts price target to 415 dollars
Investing.com
·
2 days ago
Wells Fargo raises Cencora stock price target to $400 on estimates
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc
CEORobert Mauch
Employees49K
Founded1871
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitecencora.com